Expensify director granted 1,160,447 stock options
Expensify, Inc. director Daniel Vidal reported a compensation-related grant of stock options covering 1,160,447 shares of Class A common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Expensify, Inc. director Daniel Vidal reported a compensation-related grant of stock options covering 1,160,447 shares of Class A common stock. The options have an exercise price of $1.75 per share and expire on June 23, 2036. They vest in 16 equal quarterly installments, deemed to have begun on April 12, 2025, meaning the award becomes exercisable over four years rather than all at once. Following this grant, Vidal holds 1,160,447 stock options directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 1,160,447 | $0.00 | $0.00 |
Footnotes (1)
- F1. The stock option vests in 16 equal quarterly installments, deemed to have begun on April 12, 2025
Key Figures
Key Terms
Stock Option financial
Class A Common Stock financial
vests in 16 equal quarterly installments financial
exercise price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Expensify (EXFY) director Daniel Vidal report?
What is the exercise price of Daniel Vidal’s Expensify (EXFY) stock options?
How do Daniel Vidal’s new Expensify (EXFY) options vest over time?
When do Daniel Vidal’s Expensify (EXFY) stock options expire?
How many Expensify (EXFY) stock options does Daniel Vidal hold after this grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.